Evidence map›Paper›PMID 22045558›Full record

ArticleCurrent protocols in protein science2011

Detection and analysis of proteins modified by O-linked N-acetylglucosamine.

Natasha E Zachara, Keith Vosseller, Gerald W Hart

Abstract read
In one paragraph

Article in Current protocols in protein science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Advances in chemical probing of proteinChemical Society reviews · 2021
    Review
  3. The Hitchhiker's guide to glycoproteomics.Biochemical Society transactions · 2021
    Review
  4. Article
  5. Role ofPhysiological reviews · 2021
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Nutrient regulation of signaling and transcription.The Journal of biological chemistry · 2019
    Review
  12. Review
  13. Article
  14. A Putative O-Linked β-Journal of bacteriology · 2017
    Article
  15. Analysis of Protein O-GlcNAcylation by Mass Spectrometry.Current protocols in protein science · 2017
    Article
  16. Chemical Glycoproteomics.Chemical reviews · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Natasha E ZacharaThe Johns Hopkins University School of Medicine, Baltimore, Maryland.
Keith VossellerDrexel University College of Medicine, Philadelphia, Pennsylvania.
Gerald W HartThe Johns Hopkins University School of Medicine, Baltimore, Maryland.
Johns Hopkins Medicine · USDrexel University · US

Funding

Shared Resource CoresP01HL107153 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HART, GERALD WARREN · 2011 to 2017
$16.8M
JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WONDISFORD, FREDRIC E. · 2013 to 2017
$9.7M
ROLE OF CELL-SURFACE SIALYLATION IN TUMOR METASTASISR01CA042486 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HART, GERALD WARREN · 1986 to 2013
$4.9M
Cytosolic O-Glycosylation and Insulin SignalingR01DK061671 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI HART, GERALD WARREN · 2002 to 2014
$4.0M
Mechanisms of Glucose ToxicityR24DK084949 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI HART, GERALD WARREN, HOKE, AHMET · 2010 to 2010
$492k
Defining the Molecular Mechanisms by Which O-GlcNAc Mediates CardioprotectionR21HL108003 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ZACHARA, NATASHA ELIZABETH · 2011 to 2012
$454k
Reversal of Tau Alzheimer's hyperphosphorylation by pharmacological elevation ofR21AG033226 · NIA · DREXEL UNIVERSITY · PI VOSSELLER, KEITH · 2009 to 2010
$334k
Discovery of a urine biomarker of HIV for noninvasive, point-of-care testing useR03AI083149 · NIAID · DREXEL UNIVERSITY · PI SCHLECHT, HANS P · 2010 to 2011
$154k
NCI NIH HHS R01 CA042486NCI NIH HHS R01 CA42486NHLBI NIH HHS N01-HV-00240NHLBI NIH HHS P01 HL107153NHLBI NIH HHS R21 HL108003NIAID NIH HHS R03 AI083149NIA NIH HHS R21 AG033226NIDDK NIH HHS P30 DK079637NIDDK NIH HHS R01 DK061671NIDDK NIH HHS R01 DK61671NIDDK NIH HHS R24 DK084949
6 · The paper itself

Abstract

O-GlcNAc is a common post-translational modification of nuclear, mitochondrial, and cytoplasmic proteins that is implicated in the etiology of type II diabetes and Alzheimer's disease, as well as cardioprotection. This unit covers simple and comprehensive techniques for identifying proteins modified by O-GlcNAc, studying the enzymes that add and remove O-GlcNAc, and mapping O-GlcNAc modification sites.

Indexed as

AcetylglucosamineAntibodiesCell NucleusChromatography, AffinityGalactosyltransferasesGlycosylationHexosaminidasesMitochondriaProtein Processing, Post-TranslationalProteinsAcetylglucosamineAntibodiesGalactosyltransferasesHexosaminidasesProteins

Identifiers

PMID22045558
PMCPMC3349994
OpenAlexW2164744009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.